glaucoma filtration device
Recently Published Documents


TOTAL DOCUMENTS

25
(FIVE YEARS 0)

H-INDEX

6
(FIVE YEARS 0)

Vision ◽  
2020 ◽  
Vol 4 (3) ◽  
pp. 39
Author(s):  
Michele Nicolai ◽  
Alessandro Franceschi ◽  
Paolo Pelliccioni ◽  
Vittorio Pirani ◽  
Cesare Mariotti

The EX-PRESS glaucoma filtration device appears to be an effective addition to our options to treat refractory glaucoma. The possibility to create a sclerostomy without tissue excision provides a safe and reliable outflow pathway for aqueous that is standard in size, reducing much of the variability associated with a surgical procedure. Prospective randomized studies comparing EX-PRESS implantation with trabeculectomy show encouraging results. However, complications usually encountered in filtration surgery have been reported, and EX-PRESS implantation can also lead to specific device-related complications. This article reviews the most common complications associated with this procedure.


2020 ◽  
Vol 2020 ◽  
pp. 1-6
Author(s):  
Faried Mohammed Wagdy ◽  
Adel Galal Zaky

Purpose. To compare the outcomes of Ex-PRESS glaucoma filtration device and transscleral cyclophotocoagulation (TSCP) in the management of neovascular glaucoma (NVG). Patients and Methods. A total of 30 eyes (12 express shunts and 18 TSCP) of 28 patients were included. The eyes had NVG with intraocular pressure (IOP) more than 21 mmHg of the maximally tolerated medication treatment after previous panretinal photocoagulation and antivascular endothelial growth factor (anti-VEGF) injection, with no previous history of a cyclodestruction procedure or glaucoma surgery, were randomized either for Ex-PRESS glaucoma filtration device or TSCP. The patients were followed up weekly for the first month and then monthly for 12 months as regard to the IOP, number of topical antiglaucoma drugs required, visual outcome, and postoperative complications. Results. IOP was successfully controlled with both techniques in 83.3% of the eyes. Both techniques had fewer complications and required fewer subsequent procedures. Conclusion. Both the Ex-PRESS glaucoma filtration device and TSCP might constitute safe and alternative therapeutic tools for patients with NVG. However, TSCP is an easier procedure, less time consuming, and does not require a learning curve.


2019 ◽  
Vol 63 (5) ◽  
pp. 402-409 ◽  
Author(s):  
Makoto Aihara ◽  
Yasuaki Kuwayama ◽  
Kazunori Miyata ◽  
Shinichiro Ohtani ◽  
Ryuichi Ideta ◽  
...  

2019 ◽  
Vol 112 (1) ◽  
pp. 9
Author(s):  
Sherif El-Saeed El-Kholy ◽  
Dina Abd El FattahAbd El Rehim ◽  
Abd-AlmonemAbo-Alfotouh El-Hessy ◽  
EhabHassan Nematalla ◽  
EglalMohamed El-Saeed

2016 ◽  
Vol 25 (5) ◽  
pp. 422-425 ◽  
Author(s):  
Dmitry Yarovoy ◽  
Sunita Radhakrishnan ◽  
Terri-Diann Pickering ◽  
Andrew G. Iwach

Sign in / Sign up

Export Citation Format

Share Document